| Secondary |
| Product Used For Unknown Indication |
33.9% |
| Acute Lymphocytic Leukaemia |
11.0% |
| Lung Neoplasm Malignant |
6.8% |
| Schizophrenia |
5.5% |
| Breast Cancer Metastatic |
4.7% |
| Neoplasm Malignant |
4.7% |
| Rheumatoid Arthritis |
4.7% |
| Breast Cancer |
3.4% |
| Chronic Myeloid Leukaemia |
3.0% |
| Hypertension |
3.0% |
| Lymphoma |
3.0% |
| Crohn's Disease |
2.1% |
| Nausea |
2.1% |
| Schizoaffective Disorder |
2.1% |
| Anticoagulant Therapy |
1.7% |
| Anxiety |
1.7% |
| Bone Disorder |
1.7% |
| Cardiac Failure Congestive |
1.7% |
| Gastrointestinal Carcinoma |
1.7% |
| Hypercholesterolaemia |
1.7% |
|
| Leukopenia |
23.7% |
| Granulocytopenia |
15.3% |
| Agranulocytosis |
6.8% |
| Lung Neoplasm Malignant |
5.1% |
| Pain |
5.1% |
| Weight Decreased |
5.1% |
| Confusional State |
3.4% |
| Death |
3.4% |
| Oedema Peripheral |
3.4% |
| Sepsis |
3.4% |
| Subcutaneous Nodule |
3.4% |
| Thrombocytopenia |
3.4% |
| Vomiting |
3.4% |
| Vulvovaginal Rash |
3.4% |
| White Blood Cell Count Decreased |
3.4% |
| Abdominal Rigidity |
1.7% |
| Acute Myeloid Leukaemia |
1.7% |
| Alanine Aminotransferase Increased |
1.7% |
| Blood Glucose Increased |
1.7% |
| Bundle Branch Block |
1.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
26.9% |
| Breast Cancer |
11.5% |
| Metastases To Bone |
9.6% |
| Multiple Myeloma |
7.3% |
| Breast Cancer Metastatic |
4.4% |
| Prostate Cancer |
4.2% |
| Prostate Cancer Metastatic |
3.9% |
| Osteoporosis |
3.4% |
| Neutropenia |
3.0% |
| Hypertension |
2.9% |
| Neoplasm Malignant |
2.9% |
| Diabetes Mellitus |
2.8% |
| Depression |
2.6% |
| Prophylaxis |
2.5% |
| Acute Lymphocytic Leukaemia |
2.5% |
| Pain |
2.5% |
| Lung Neoplasm Malignant |
2.1% |
| Bone Disorder |
1.8% |
| Chemotherapy |
1.7% |
| Chronic Myeloid Leukaemia |
1.6% |
|
| Febrile Neutropenia |
9.7% |
| Death |
9.3% |
| Weight Decreased |
7.8% |
| Pyrexia |
6.6% |
| Osteonecrosis Of Jaw |
6.2% |
| White Blood Cell Count Decreased |
6.2% |
| Neoplasm Malignant |
5.8% |
| Malaise |
5.4% |
| Vomiting |
5.0% |
| Nausea |
3.9% |
| Neutropenia |
3.9% |
| Neutrophil Count Decreased |
3.9% |
| Pain |
3.9% |
| Cardiac Disorder |
3.5% |
| Drug Ineffective |
3.5% |
| Thrombocytopenia |
3.5% |
| Dyspnoea |
3.1% |
| Osteonecrosis |
3.1% |
| Pain In Extremity |
3.1% |
| Lung Neoplasm Malignant |
2.7% |
|
| Interacting |
| Asthma |
33.3% |
| Neoplasm Malignant |
33.3% |
| Schizophrenia |
33.3% |
|
|
